Stocks: Overview  

Sunday, May 19, 2013 7:00:40 AM EDT
Show Me
|

 

ImmunoCellular Therapeutics LtdIMUC
PowerShares QQQ Trust, Series 1QQQ
Cigna CorpCI
Blue Nile IncNILE
Global X Uranium ETFURA
CytRx CorpCYTR
Alcoa IncAA
Touchstone Small Cap Growth Fund Class YMXAIX
Pep Boys-Manny Moe and JackPBY
LinkedIn CorpLNKD

ImmunoCellular Therapeutics LtdNYSE MKT LLC:IMUC    

Health Care : BiotechnologySmall Cap Growth
$2.56 
 0.01 (0.39%)        
Bid
--
Ask
--
B/A Size
--
High
2.60
Low
2.54
Volume
307,302 (Below Avg)
Change company  Symbol lookup
As of May 17, 2013 4:01pm ET
  • Summary
  • News
  • Charts
  • Earnings
  • Fundamentals
  • Valuation
  • Calendar
  • Analyst Reports
  • SEC Filings

2.57

135.0M


2.60

52.7M


2.54 - 2.60

-0.27


388.7K

--


4:01p ET 05/17/13

No Regular Dividends


11.9K

--


Low
High

1.1


36.00%

15.78


77.8%

7.78


66.0%

Historical Quotes & Splits
 

Current|1mo|3mo|6mo|1yr
DJIA
S&P 500
NASDAQ
SMA(50)
View Advanced Chart
  • News
  • Industry Position
  • Company Profile

May 16, 2013

6:00a
ImmunoCellular Therapeutics Announces Issuance of Key Patent Covering ICT-107 Cancer Vaccine Target   (Business Wire)

May 9, 2013

4:00p
ImmunoCellular Therapeutics Announces First Quarter 2013 Financial Results   (Business Wire)

May 1, 2013

6:00a
ImmunoCellular Therapeutics to Report Financial Results for the First Quarter 2013 May 9, 2013   (Business Wire)

March 28, 2013

6:00a
ImmunoCellular Therapeutics to Present at Future Leaders Conference on April 5th   (Business Wire)

March 11, 2013

4:35p
ImmunoCellular Therapeutics to Present at ROTH Conference on March 18th   (Business Wire)

March 7, 2013

8:15a
NW Bio Provides Guidance On Phase III Trial Enrollment Timing: Completion Expected To Be Faster Or More Efficient Than Relevant Comparison Trials   (PR NewsWire)

March 5, 2013

4:00p
ImmunoCellular Therapeutics Announces Fourth Quarter and Full Year 2012 Financial Results   (Business Wire)

March 4, 2013

6:00a
ImmunoCellular Therapeutics Announces Issuance of Key Patent for ICT-121 Cancer Vaccine   (Business Wire)

February 26, 2013

6:00a
ImmunoCellular Therapeutics to Report Financial Results for the Fourth Quarter and Full Year 2012 on March 5, 2013   (Business Wire)

December 4, 2012

9:23a
UPDATE 1: Tuesday's biggest gaining and declining stocks   (MarketWatch)
Go to All Current & Historical News
Events
05/09/2013
Q1 2013 ImmunoCellular Therapeutics Ltd Earnings Release - Estimate: $-0.10
03/05/2013
Q4 2012 ImmunoCellular Therapeutics Ltd Earnings Release - Estimate: $0.01
11/12/2012
Q3 2012 ImmunoCellular Therapeutics Ltd Earnings Release - Estimate: $-0.02
08/15/2012
Q2 2012 ImmunoCellular Therapeutics Ltd Earnings Release - Estimate: $-0.16
More Calendar Events
Market data accompanied by       is delayed by at least 15 minutes for NASDAQ, AMEX, NYSE and Options. Duration of the delay for other exchanges vary.
THOMSON REUTERS  
Market data and information provided by Thomson Reuters; ©  
Thomson Reuters Limited.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.
Information and news provided by 
, 
Computrade Systems, Inc., 
 , 
,  
, 
and 

Copyright ©2013. All rights reserved.


S&P Capital IQ Research Disclosure /public-7:0:39

3rd Party Research Disclosure /public-7:0:39

Market Data Disclosure